Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice

Blood

Volumn 120, Issue 3, 2012, Pages 592-602

  Beĺanger, Simon ^a   Tu, Megan M ^b   Rahim, Mir Munir Ahmed ^b   Mahmoud, Ahmad B ^b   Patel, Rajen ^b   Tai, Lee Hwa ^a   Troke, Angela D ^b   Wilhelm, Brian T ^c   Landry, Josette Renée ^c   Zhu, Qinzhang ^d   Tung, Kenneth S ^e   Raulet, David H ^f   Makrigiannis, Andrew P ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^e UNIVERSITY OF VIRGINIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT REJECTION; IMMUNOSURVEILLANCE; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL DESTRUCTION;

EID: 84864138003     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-408732     Document Type: Article

References (38)

1. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320(26):1731- 1735.
2. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol. 2006;6(6):399-409. (Pubitemid 44714151)
3. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986;319(6055):675-678. (Pubitemid 16119452)
4. Carlyle JR, Mesci A, Fine JH, et al. Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol. 2008;20(6):321-330.
5. Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun. 2005;6(2):71-83. (Pubitemid 40439532)
6. Pyzik M, Charbonneau B, Gendron-Pontbriand EM, et al. Distinct MHC class I-dependent-activating receptors control cytomegalovirus infection in different mouse strains. J Exp Med. 2011;208(5):1105-1117.
7. Fernandez NC, Treiner E, Vance RE, et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 2005;105(11): 4416-4423. (Pubitemid 40720789)
8. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709-713. (Pubitemid 41117274)
9. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood. 2009;113(11):2434- 2441.
10. Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med. 1997;185(12): 2079-2088. (Pubitemid 27265991)
11. Hanke T, Takizawa H, McMahon CW, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 1999; 11(1):67-77. (Pubitemid 29359958)
12. Liu J, Morris MA, Nguyen P, et al. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J Immunol. 2000;164(4):1793-1799. (Pubitemid 30108731)
13. Champsaur M, Beilke JN, Ogasawara K, et al. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol. 2010;185(1):157-165.
14. Patel R, Belanger S, Tai LH, Troke AD, Makrigiannis AP. Effect of Ly49 haplotype variance on NK cell function and education. J Immunol. 2010;185(8):4783-4792.
15. Belanger S, Tai LH, Anderson SK, MakrigiannisAP. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun. 2008;9(6): 509-521.
16. Makrigiannis AP, Pau AT, Schwartzberg PL, et al. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics. 2002; 79(3):437-444. (Pubitemid 34211952)
17. Carlyle JR, Mesci A, Ljutic B, et al. Molecular and genetic basis for strain-dependent NK1.1 allore-activity of mouse NK cells. J Immunol. 2006; 176(12):7511-7524. (Pubitemid 43849055)
18. Saether PC, Westgaard IH, Flornes LM, et al. Molecular cloning of KLRI1 and KLRI2, a novel pair of lectin-like natural killer-cell receptors with opposing signalling motifs. Immunogenetics. 2005;56(11):833-839. (Pubitemid 40558086)
19. Tai LH, Goulet ML, Belanger S, et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med. 2008;205(13):3187-3199.
20. Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol. 2000;30(3):920-930. (Pubitemid 30216267)
21. Scarpellino L, Oeschger F, Guillaume P, et al. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J Immunol. 2007; 178(3):1277-1284. (Pubitemid 46154597)
22. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol. 2000; 1(2):119-126.
23. Piontek GE, Taniguchi K, Ljunggren HG, et al. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol. 1985;135(6):4281- 4288.
24. Orr MT, Beilke JN, Proekt I, Lanier LL. Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus. Proc Natl Acad Sci U S A. 2010;107(36):15844-15849.
25. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A. 1996;93(23):13090-13095. (Pubitemid 26382774)
26. Tanamachi DM, Moniot DC, Cado D, et al. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol. 2004; 172(2):1074-1082. (Pubitemid 38113767)
27. Saleh A, Davies GE, Pascal V, et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity. 2004;21(1): 55-66. (Pubitemid 38925267)
28. Smith E, Shilatifard A. The A, B, Gs of silencing. Genes Dev. 2007;21(10):1141-1144. (Pubitemid 46789870)
29. Chang CS, Brossay L, Kronenberg M, Kane KP. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J Exp Med. 1999;189(3):483-491. (Pubitemid 29187370)
30. Chiang EY, Henson M, Stroynowski I. The non-classical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. J Immunol. 2002;168(5):2200-2211. (Pubitemid 34171819)
31. Salcedo M, Colucci F, Dyson PJ, et al. Role of Qa-1(b)-binding receptors in the specificity of developing NK cells. Eur J Immunol. 2000;30(4): 1094-1101. (Pubitemid 30216226)
32. Tajima A, Tanaka T, Ebata T, et al. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. J Immunol. 2003;171(4):1715-1721. (Pubitemid 36966454)
33. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. 1998;188(10):1841-1848. (Pubitemid 28536771)
34. Johansson S, Johansson M, Rosmaraki E, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med. 2005;201(7):1145-1155. (Pubitemid 40524682)
35. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol. 2010;11(4):321- 327.
36. Dorfman JR, Zerrahn J, Coles MC, Raulet DH. The basis for self-tolerance of natural killer cells in beta2-microglobulin and TAP-1 mice. J Immunol. 1997;159(11):5219-5225. (Pubitemid 127470047)
37. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 1991;253(5016):199-202. (Pubitemid 21917142)
38. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6(7):520-531. (Pubitemid 43980524)